| Stage | CMI | % of rev | PSIX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.4B | 100.00% | $153M | 100.00% | CMI ×61.87 |
| Gross profit | $2.6B | 27.71% | $41M | 27.12% | CMI +0.6pp |
| Operating income | $1.3B | 13.95% | $24M | 15.68% | PSIX +1.7pp |
| Pre-tax income | $1.4B | 15.05% | $22M | 14.73% | CMI +0.3pp |
| Net income | $1.2B | 12.39% | $17M | 11.05% | CMI +1.3pp |
| Stage | CMI | PSIX | Gap · A − B |
|---|---|---|---|
| Revenue | $9.4B100.00% | $153M100.00% | CMI ×61.87 |
| Gross profit | 27.71%$2.6B | 27.12%$41M | CMI +0.6pp |
| Operating income | 13.95%$1.3B | 15.68%$24M | PSIX +1.7pp |
| Pre-tax income | 15.05%$1.4B | 14.73%$22M | CMI +0.3pp |
| Net income |
| 12.39%$1.2B |
| 11.05%$17M |
| CMI +1.3pp |
No shared counterparties.